PMC:7283670 / 49945-50404 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T174","span":{"begin":16,"end":21},"obj":"Body_part"},{"id":"T175","span":{"begin":105,"end":113},"obj":"Body_part"}],"attributes":[{"id":"A174","pred":"fma_id","subj":"T174","obj":"http://purl.org/sig/ont/fma/fma50801"},{"id":"A175","pred":"fma_id","subj":"T175","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":" N‐terminal‐pro brain natriuretic peptide: Higher in 16(57.1%) men/5 (26.3%) women,\nPositive influenza A antibody: 5 men (17.9%) Fever: 34 [72.3%], cough: 36 [76.6%], myalgia: 5 [10.6%], fatigue: 7 [14.9%]/comorbidities: 30 (63.8%):\nCOPD, hypertension/CVD lower in men – 3.6% in men and 0 in women Therapy:\nantibiotics applied more in the men than the women\nResults and interpretation: 4 (21.1%) women/1 man (3.6%) discharged.\nPossibility of sex differenc"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T120","span":{"begin":16,"end":21},"obj":"Body_part"}],"attributes":[{"id":"A120","pred":"uberon_id","subj":"T120","obj":"http://purl.obolibrary.org/obo/UBERON_0000955"}],"text":" N‐terminal‐pro brain natriuretic peptide: Higher in 16(57.1%) men/5 (26.3%) women,\nPositive influenza A antibody: 5 men (17.9%) Fever: 34 [72.3%], cough: 36 [76.6%], myalgia: 5 [10.6%], fatigue: 7 [14.9%]/comorbidities: 30 (63.8%):\nCOPD, hypertension/CVD lower in men – 3.6% in men and 0 in women Therapy:\nantibiotics applied more in the men than the women\nResults and interpretation: 4 (21.1%) women/1 man (3.6%) discharged.\nPossibility of sex differenc"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T297","span":{"begin":93,"end":102},"obj":"Disease"},{"id":"T298","span":{"begin":234,"end":238},"obj":"Disease"},{"id":"T299","span":{"begin":240,"end":252},"obj":"Disease"}],"attributes":[{"id":"A297","pred":"mondo_id","subj":"T297","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A298","pred":"mondo_id","subj":"T298","obj":"http://purl.obolibrary.org/obo/MONDO_0005002"},{"id":"A299","pred":"mondo_id","subj":"T299","obj":"http://purl.obolibrary.org/obo/MONDO_0005044"}],"text":" N‐terminal‐pro brain natriuretic peptide: Higher in 16(57.1%) men/5 (26.3%) women,\nPositive influenza A antibody: 5 men (17.9%) Fever: 34 [72.3%], cough: 36 [76.6%], myalgia: 5 [10.6%], fatigue: 7 [14.9%]/comorbidities: 30 (63.8%):\nCOPD, hypertension/CVD lower in men – 3.6% in men and 0 in women Therapy:\nantibiotics applied more in the men than the women\nResults and interpretation: 4 (21.1%) women/1 man (3.6%) discharged.\nPossibility of sex differenc"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T498","span":{"begin":16,"end":21},"obj":"http://purl.obolibrary.org/obo/UBERON_0000955"},{"id":"T499","span":{"begin":16,"end":21},"obj":"http://www.ebi.ac.uk/efo/EFO_0000302"},{"id":"T500","span":{"begin":34,"end":41},"obj":"http://purl.obolibrary.org/obo/PR_000018263"},{"id":"T501","span":{"begin":103,"end":104},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T502","span":{"begin":137,"end":139},"obj":"http://purl.obolibrary.org/obo/CLO_0001302"},{"id":"T503","span":{"begin":156,"end":158},"obj":"http://purl.obolibrary.org/obo/CLO_0001313"}],"text":" N‐terminal‐pro brain natriuretic peptide: Higher in 16(57.1%) men/5 (26.3%) women,\nPositive influenza A antibody: 5 men (17.9%) Fever: 34 [72.3%], cough: 36 [76.6%], myalgia: 5 [10.6%], fatigue: 7 [14.9%]/comorbidities: 30 (63.8%):\nCOPD, hypertension/CVD lower in men – 3.6% in men and 0 in women Therapy:\nantibiotics applied more in the men than the women\nResults and interpretation: 4 (21.1%) women/1 man (3.6%) discharged.\nPossibility of sex differenc"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T78285","span":{"begin":16,"end":41},"obj":"Chemical"},{"id":"T88212","span":{"begin":34,"end":41},"obj":"Chemical"},{"id":"T91945","span":{"begin":311,"end":322},"obj":"Chemical"}],"attributes":[{"id":"A48508","pred":"chebi_id","subj":"T78285","obj":"http://purl.obolibrary.org/obo/CHEBI_80234"},{"id":"A72928","pred":"chebi_id","subj":"T88212","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"},{"id":"A55758","pred":"chebi_id","subj":"T91945","obj":"http://purl.obolibrary.org/obo/CHEBI_33281"}],"text":" N‐terminal‐pro brain natriuretic peptide: Higher in 16(57.1%) men/5 (26.3%) women,\nPositive influenza A antibody: 5 men (17.9%) Fever: 34 [72.3%], cough: 36 [76.6%], myalgia: 5 [10.6%], fatigue: 7 [14.9%]/comorbidities: 30 (63.8%):\nCOPD, hypertension/CVD lower in men – 3.6% in men and 0 in women Therapy:\nantibiotics applied more in the men than the women\nResults and interpretation: 4 (21.1%) women/1 man (3.6%) discharged.\nPossibility of sex differenc"}

{"project":"LitCovid-sentences","denotations":[{"id":"T557","span":{"begin":43,"end":83},"obj":"Sentence"},{"id":"T558","span":{"begin":84,"end":114},"obj":"Sentence"},{"id":"T559","span":{"begin":115,"end":136},"obj":"Sentence"},{"id":"T560","span":{"begin":137,"end":155},"obj":"Sentence"},{"id":"T561","span":{"begin":156,"end":176},"obj":"Sentence"},{"id":"T562","span":{"begin":177,"end":196},"obj":"Sentence"},{"id":"T563","span":{"begin":197,"end":221},"obj":"Sentence"},{"id":"T564","span":{"begin":222,"end":233},"obj":"Sentence"},{"id":"T565","span":{"begin":234,"end":310},"obj":"Sentence"},{"id":"T566","span":{"begin":311,"end":361},"obj":"Sentence"},{"id":"T567","span":{"begin":362,"end":389},"obj":"Sentence"},{"id":"T568","span":{"begin":390,"end":430},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" N‐terminal‐pro brain natriuretic peptide: Higher in 16(57.1%) men/5 (26.3%) women,\nPositive influenza A antibody: 5 men (17.9%) Fever: 34 [72.3%], cough: 36 [76.6%], myalgia: 5 [10.6%], fatigue: 7 [14.9%]/comorbidities: 30 (63.8%):\nCOPD, hypertension/CVD lower in men – 3.6% in men and 0 in women Therapy:\nantibiotics applied more in the men than the women\nResults and interpretation: 4 (21.1%) women/1 man (3.6%) discharged.\nPossibility of sex differenc"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T187","span":{"begin":130,"end":135},"obj":"Phenotype"},{"id":"T188","span":{"begin":149,"end":154},"obj":"Phenotype"},{"id":"T189","span":{"begin":168,"end":175},"obj":"Phenotype"},{"id":"T190","span":{"begin":188,"end":195},"obj":"Phenotype"},{"id":"T191","span":{"begin":234,"end":238},"obj":"Phenotype"},{"id":"T192","span":{"begin":240,"end":252},"obj":"Phenotype"}],"attributes":[{"id":"A187","pred":"hp_id","subj":"T187","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A188","pred":"hp_id","subj":"T188","obj":"http://purl.obolibrary.org/obo/HP_0012735"},{"id":"A189","pred":"hp_id","subj":"T189","obj":"http://purl.obolibrary.org/obo/HP_0003326"},{"id":"A190","pred":"hp_id","subj":"T190","obj":"http://purl.obolibrary.org/obo/HP_0012378"},{"id":"A191","pred":"hp_id","subj":"T191","obj":"http://purl.obolibrary.org/obo/HP_0006510"},{"id":"A192","pred":"hp_id","subj":"T192","obj":"http://purl.obolibrary.org/obo/HP_0000822"}],"text":" N‐terminal‐pro brain natriuretic peptide: Higher in 16(57.1%) men/5 (26.3%) women,\nPositive influenza A antibody: 5 men (17.9%) Fever: 34 [72.3%], cough: 36 [76.6%], myalgia: 5 [10.6%], fatigue: 7 [14.9%]/comorbidities: 30 (63.8%):\nCOPD, hypertension/CVD lower in men – 3.6% in men and 0 in women Therapy:\nantibiotics applied more in the men than the women\nResults and interpretation: 4 (21.1%) women/1 man (3.6%) discharged.\nPossibility of sex differenc"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1188","span":{"begin":63,"end":66},"obj":"Species"},{"id":"1189","span":{"begin":77,"end":82},"obj":"Species"},{"id":"1190","span":{"begin":117,"end":120},"obj":"Species"},{"id":"1191","span":{"begin":266,"end":269},"obj":"Species"},{"id":"1192","span":{"begin":282,"end":285},"obj":"Species"},{"id":"1193","span":{"begin":343,"end":346},"obj":"Species"},{"id":"1194","span":{"begin":400,"end":405},"obj":"Species"},{"id":"1210","span":{"begin":93,"end":102},"obj":"Species"},{"id":"1212","span":{"begin":295,"end":300},"obj":"Species"},{"id":"1386","span":{"begin":130,"end":135},"obj":"Disease"},{"id":"1387","span":{"begin":149,"end":154},"obj":"Disease"},{"id":"1388","span":{"begin":168,"end":175},"obj":"Disease"},{"id":"1389","span":{"begin":188,"end":195},"obj":"Disease"},{"id":"1390","span":{"begin":234,"end":238},"obj":"Disease"},{"id":"1391","span":{"begin":240,"end":252},"obj":"Disease"},{"id":"1392","span":{"begin":253,"end":256},"obj":"Disease"}],"attributes":[{"id":"A1188","pred":"tao:has_database_id","subj":"1188","obj":"Tax:9606"},{"id":"A1189","pred":"tao:has_database_id","subj":"1189","obj":"Tax:9606"},{"id":"A1190","pred":"tao:has_database_id","subj":"1190","obj":"Tax:9606"},{"id":"A1191","pred":"tao:has_database_id","subj":"1191","obj":"Tax:9606"},{"id":"A1192","pred":"tao:has_database_id","subj":"1192","obj":"Tax:9606"},{"id":"A1193","pred":"tao:has_database_id","subj":"1193","obj":"Tax:9606"},{"id":"A1194","pred":"tao:has_database_id","subj":"1194","obj":"Tax:9606"},{"id":"A1210","pred":"tao:has_database_id","subj":"1210","obj":"Tax:11309"},{"id":"A1212","pred":"tao:has_database_id","subj":"1212","obj":"Tax:9606"},{"id":"A1386","pred":"tao:has_database_id","subj":"1386","obj":"MESH:D005334"},{"id":"A1387","pred":"tao:has_database_id","subj":"1387","obj":"MESH:D003371"},{"id":"A1388","pred":"tao:has_database_id","subj":"1388","obj":"MESH:D063806"},{"id":"A1389","pred":"tao:has_database_id","subj":"1389","obj":"MESH:D005221"},{"id":"A1390","pred":"tao:has_database_id","subj":"1390","obj":"MESH:D029424"},{"id":"A1391","pred":"tao:has_database_id","subj":"1391","obj":"MESH:D006973"},{"id":"A1392","pred":"tao:has_database_id","subj":"1392","obj":"MESH:D002318"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" N‐terminal‐pro brain natriuretic peptide: Higher in 16(57.1%) men/5 (26.3%) women,\nPositive influenza A antibody: 5 men (17.9%) Fever: 34 [72.3%], cough: 36 [76.6%], myalgia: 5 [10.6%], fatigue: 7 [14.9%]/comorbidities: 30 (63.8%):\nCOPD, hypertension/CVD lower in men – 3.6% in men and 0 in women Therapy:\nantibiotics applied more in the men than the women\nResults and interpretation: 4 (21.1%) women/1 man (3.6%) discharged.\nPossibility of sex differenc"}